IP Library Granted Patent US 11,820,812
Granted Patent B2
US 11,820,812 · App. 17/564,962 · Granted Nov 21, 2023

RSV F protein compositions and methods for making same

Inventors: Kurt Swanson (Newton, MA); Philip R. Dormitzer (Weston, MA)
Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
C07K16/1027A61K39/12A61K39/155C07K14/005A61K39/00A61K2039/5252A61K2039/5256A61K2039/5258A61K2039/53A61K2039/55505A61K2039/55555A61K2039/55561A61K2039/55566A61K2039/55572C07K2317/76C07K2319/00C07K2319/21C07K2319/50C07K2319/73C12N2760/18522C12N2760/18534C12N2770/36143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,820,812
App. No.
17/564,962
Granted
Nov 21, 2023
Kind
B2
Abstract

The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered RSV F proteins and nucleic acids that encode the engineered RSV F proteins. Compositions prepared using the methods can contain RSV F protein ecto-domain polypeptides in a predominant or single desired form and conformation. The invention also relates to methods for inducing an immune response to RSV F.

Claims (15)

1. A respiratory syncytial virus (RSV)-F heterodimer comprising a F1 subunit, a F2 subunit, and an oligomerization domain, wherein:

the F1 subunit comprises an amino acid sequence at least 95% identical to the F1 subunit of SEQ ID NO: 1;

the F2 subunit comprises an amino acid sequence at least 95% identical to the F2 subunit of SEQ ID NO: 1; and

the oligomerization domain is a trimerizing sequence from bacteriophage T4 fibritin comprising amino acid residues 3-29 of SEQ ID NO: 19.

2. The RSV-F heterodimer of claim 1 , wherein the F1 subunit comprises an amino acid sequence at least 95% identical to amino acids 137-574 of SEQ ID NO: 1; and the F2 subunit comprises an amino acid sequence at least 95% identical to amino acids 22 to 109 of SEQ ID NO: 1.

3. The RSV-F heterodimer of claim 1 , wherein the trimerizing sequence from bacteriophage T4 fibritin is attached to a C-terminus of the F1 subunit.

4. The RSV-F heterodimer of claim 3 , wherein the trimerizing sequence is attached to the C-terminus of the F1 subunit with a linker sequence.

5. A RSV-F F1-F2 homotrimer comprising three RSV-F heterodimers of claim 1 .

6. A nucleic acid encoding the RSV-F heterodimer of claim 1 .

7. A vector comprising the nucleic acid of claim 6 .

8. A host cell comprising the vector of claim 7 .

9. A method of making a RSV-F heterodimer comprising a F1 subunit, a F2 subunit, and an oligomerization domain, wherein: the F1 subunit comprises an amino acid sequence at least 95% identical to the F1 subunit of SEQ ID NO: 1; the F2 subunit comprises an amino acid sequence at least 95% identical to the F2 subunit of SEQ ID NO: 1, and the oligomerization domain is a trimerizing sequence from bacteriophage T4 fibritin comprising amino acid residues 3-29 of SEQ ID NO: 19, the method comprising: culturing the host cell of claim 8 and recovering the heterodimer from a culture media.

10. An immunogenic composition comprising the RSV-F heterodimer of claim 1 .

11. The immunogenic composition of claim 10 , further comprising an adjuvant.

12. A method of inducing an immune response to RSV in a subject, the method comprising administering an effective amount of the immunogenic composition of claim 10 to the subject.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2022
From: SWANSON, KURT; DORMITZER, PHILIP R
To: NOVARTIS VACCINES & DIAGNOSTICS, INC.
Reel/Frame 058572/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2022
From: CHIRON CORPORATION
To: NOVARTIS VACCINES & DIAGNOSTICS, INC.
Reel/Frame 058572/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2022
From: NOVARTIS AG
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 058573/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2022
From: NOVARTIS VACCINES & DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 058585/0660 →